These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7958725)

  • 41. Partial agonist activity of celiprolol.
    Tung LH; Jackman G; Campbell B; Louis S; Iakovidis D; Louis WJ
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):484-8. PubMed ID: 7681512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The in vitro pharmacology of xamoterol (ICI 118,587).
    Malta E; Mian MA; Raper C
    Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-receptor blocking potencies of the three newly synthesized beta-adrenergic antagonists (S-596, K-351, N-696) as assessed with the radioligand binding assay method in rat cardiac muscle membrane treated with neuraminidase.
    Nagatomo T; Tsuchihashi H; Sasaki M; Nakagawa Y; Nakahara H; Imai S
    Jpn J Pharmacol; 1984 Feb; 34(2):249-54. PubMed ID: 6205196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and functional role of beta-adrenergic receptor subtypes in primate and rodent: in vivo versus isolated myocytes.
    Cui Y; Shen YT; Kalthof B; Iwase M; Sato N; Uechi M; Vatner SF; Vatner DE
    J Mol Cell Cardiol; 1996 Jun; 28(6):1307-17. PubMed ID: 8782072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
    Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
    Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bis-arenoxypropanolamines as potential beta-adrenolytics: a reinvestigation.
    Da Re P; Valenti P; Fabbri G; Frigeni V; Reggiani A; Della Bella D
    Drugs Exp Clin Res; 1988; 14(11):687-92. PubMed ID: 2907738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Pharmacology; 1989; 39(5):327-36. PubMed ID: 2575762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
    Malinowska B; Schlicker E
    Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of chronic administration of bopindolol on the binding characteristics of cardiac alpha 1H-, alpha 1L-, beta 1- and beta 2-adrenoceptor subtypes in cardiac muscles of spontaneously hypertensive rats (SHR).
    Hosohata Y; Sasaki K; Maruyama K; Ohnuki T; Hattori K; Suzuki J; Watanabe K; Nagatomo T
    Biol Pharm Bull; 1996 Jul; 19(7):932-5. PubMed ID: 8839963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular and beta-adrenergic blocking effects of timolol.
    Mouillé P; Schmitt H; Cheymol G; Gauter E
    Eur J Pharmacol; 1976 Feb; 35(2):235-43. PubMed ID: 2481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
    Kaumann AJ; Molenaar P
    Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro studies on cetamolol, a new potent cardioselective beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity.
    Grimes D; Stern M; Wojdan A; Cummings JR
    Can J Physiol Pharmacol; 1983 Oct; 61(10):1109-15. PubMed ID: 6139156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
    Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative assessment of beta-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: similarity of inotropic and chronotropic blocking potencies against isoproterenol.
    Kaumann AJ; McInerny TK; Gilmour DP; Blinks JR
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 311(3):219-36. PubMed ID: 6104792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemodynamic effects of arotinolol in anesthetized dogs and its affinities for adrenoceptors in vitro.
    Hashimoto H; Asano M; Hayashi T; Oguro K; Takiguchi Y; Nakashima M
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):23-34. PubMed ID: 6202253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid solubility of vasodilatory vanilloid-type beta-blockers on the functional and binding activities of beta-adrenoceptor subtypes.
    Wu BN; Shen KP; Lin RJ; Huang YC; Chiang LC; Lo YC; Lin CY; Chen IJ
    Gen Pharmacol; 2000 May; 34(5):321-8. PubMed ID: 11368887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacology of ASL-8052, a novel beta-adrenergic receptor antagonist with an ultrashort duration of action.
    Gorczynski RJ; Shaffer JE; Lee RJ
    J Cardiovasc Pharmacol; 1983; 5(4):668-77. PubMed ID: 6193366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.